PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration for Targeted Alpha Therapy Candidate PACS Q1 2026 Earnings EPS Surges Past Estimates by Nearly 40 Despite Share Decline CFTC Escalates Regulatory Battle Sues Rhode Island Over Prediction Market Oversight